Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00819728 | Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer |
| terminated |
| Phase 1 / Phase 2 |
| 75 |
| AbbottINDUSTRY |
| 4 |
| Jan 7, 2011 |
| clinicaltrials |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | Eli Lilly and CompanyINDUSTRY | 4 | Dec 28, 2010 | clinicaltrials |
| NCT00321815 | Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 43 | PfizerINDUSTRY | 1 | Dec 23, 2010 | clinicaltrials |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2010 | clinicaltrials |
| NCT01260480 | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | unknown | Phase 2 | 60 | Aposense Ltd.INDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | completed | Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00434668 | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer(TOLEDO) | completed | Phase 2 | 99 | University Hospital, AntwerpOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | completed | Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00452881 | Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC | unknown | Phase 2 | 151 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00453115 | Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 43 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00874328 | A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 74 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT01222936 | LBH Phase II in Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 21 | Southern Europe New Drug OrganizationOTHER | 2 | Oct 18, 2010 | clinicaltrials |
| NCT00101920 | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Oct 15, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00430261 | Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | completed | Phase 2 | 20 | Swedish Medical CenterOTHER | 1 | Oct 6, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT01210053 | Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | Third Military Medical UniversityOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | completed | Phase 2 | 53 | Fox Chase Cancer CenterOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT01192230 | Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00925210 | Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach | completed | Phase 2 | 60 | University of CalgaryOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 3 | Sep 9, 2010 | clinicaltrials |
| NCT01192243 | Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Sep 3, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00544960 | A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 27, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
| NCT01187290 | Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | unknown | Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2010 | clinicaltrials |
| NCT00356525 | Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor | terminated | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 3 | Aug 17, 2010 | clinicaltrials |
| NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 46 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00673569 | Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | completed | Phase 2 | 40 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT01058785 | Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer | completed | Phase 2 | 75 | NovaRx CorporationINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00193388 | Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00193401 | Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT01170923 | FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 100 | Asan Medical CenterOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00826852 | Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax | completed | Phase 2 | 49 | SanofiINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00452803 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 102 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00453167 | Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | completed | Phase 2 | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | unknown | Phase 2 | 134 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00563160 | Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery | unknown | Phase 2 | 50 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00344773 | First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation | completed | Phase 2 | 46 | AstraZenecaINDUSTRY | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00193245 | Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | completed | Phase 2 | 346 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193349 | Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | Jun 28, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01145924 | Transbronchial Needle Forceps for Endobronchial Ultrasound | unknown | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Jun 17, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT00003154 | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jan 11, 2011source: clinicaltrials